SCHEMBL4780299

SCHEMBL4780299

O=S(=O)(Nc1ccc(O)cc1-c1ncco1)c1cccc(F)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.41
AXL P30530 1/20 0.41
BRAF P15056 2/20 0.40
DYRK1A Q13627 1/20 0.40
CYP2C9 P11712 1/20 0.40
LMNA P02545 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
KAT6A Q92794 1/20 0.39
KMT2A Q03164 2/20 0.39
POLB P06746 2/20 0.39
MEN1 O00255 1/20 0.39
NPC1 O15118 1/20 0.39
PKM P14618 1/20 0.39
BRD4 O60885 1/20 0.39
HSP90AA1 P07900 1/20 0.39
HSP90AB1 P08238 1/20 0.39
KIT P10721 1/20 0.39
HSPD1 P10809 2/20 0.39
PTPN2 P17706 2/20 0.39
PTPN1 P18031 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3101445 0.91 HSP90AA1 (0.41) CYP3A4AXLBRAFDYRK1ACYP2C9
SCHEMBL4781338 0.87 SLC40A1 (0.48) LMNASMN1; SMN2KMT2AMEN1PTPN2
SCHEMBL4779280 0.86 SLC40A1 (0.51) AXLBRAFLMNAKMT2AMEN1
SCHEMBL4780017 0.84 KAT6A (0.39) BRAFKAT6AKMT2AMEN1PKM
SCHEMBL3098055 0.84 AXL (0.52) CYP3A4AXLCYP2C9KMT2AMEN1
SCHEMBL3091703 0.84 CCR9 (0.43) KMT2AMEN1
SCHEMBL4781354 0.83 BRAF (0.42) BRAFKMT2APOLBMEN1HSP90AA1
SCHEMBL4780645 0.83 PIK3CD (0.43) POLBKITALDH1A1
SCHEMBL4775781 0.81 ALDH1A1 (0.46) LMNAKMT2APOLBMEN1NPC1
SCHEMBL4781817 0.78 SLC40A1 (0.48) HSP90AA1HSP90AB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008008374-A2 CCR2 INHIBITORS AND METHODS OF USE THEREOF CHEMOCENTRYX, INC. (US) 2008-01-17 WO claimed
WO-2008008374-A2 CCR2 INHIBITORS AND METHODS OF USE THEREOF CHEMOCENTRYX, INC. (US) 2008-01-17 WO disclosed